September 1, 2025

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unlocking a 30.99% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has captured the attention of investors in the biotechnology sector, a notoriously volatile yet potentially rewarding industry. With a market capitalization of $1.78 billion, Sarepta..

Soleno Therapeutics, Inc. (SLNO)

⚠️ No article content returned.

..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating a 66.8% Revenue Growth in Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the healthcare sector, particularly within the biotechnology industry. With its focus on rare neuroendocrine diseases, Rhythm’s lead product, IMCIVREE (setmelanotide), is..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 43% Potential Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV) stands at the intersection of biotechnology innovation and investor interest with its ambitious pipeline and strategic focus on unmet medical needs. With a market capitalization..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: Exploring a 21.18% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is capturing the attention of individual investors with its promising growth metrics and compelling analyst ratings. Operating within the healthcare sector, specifically in the..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating the 88.67% Potential Upside

Moderna, Inc. (NASDAQ: MRNA), a biotechnology powerhouse renowned for its pioneering work in messenger RNA (mRNA) medicines, is currently navigating a complex financial landscape. With a market capitalization of $9.37..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Look at the 38% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a noteworthy player in the biotechnology sector, specializing in innovative treatments for B-cell mediated diseases. With a market capitalization of $4.65 billion, this..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 37.51% Potential Upside for Investors

Investors looking into the healthcare sector, particularly within the medical devices industry, should not overlook Bruker Corporation (NASDAQ: BRKR). With a market capitalization of $5.16 billion, Bruker is a prominent..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 5.25% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents an intriguing proposition. With its headquarters in Melville, New York, this medical distribution giant has been..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 21.69% Upside Potential

Investors seeking opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling option. With a market capitalization of $3.35 billion, Prestige Consumer Healthcare stands as..

Alkermes plc (ALKS) Stock Analysis: Exploring a 43.25% Upside Potential with a Strong Buy Consensus

Investors eyeing opportunities in the healthcare sector may find Alkermes plc (NASDAQ: ALKS) an intriguing prospect. With its roots firmly planted in Dublin, Ireland, this biopharmaceutical company boasts a rich..

Chemed Corp (CHE) Stock Analysis: Exploring a Potential 23.87% Upside in the Healthcare Sector

Chemed Corp (CHE), a stalwart in the healthcare sector, is drawing investor attention with a notable potential upside of 23.87%, according to analyst ratings. With a current market cap of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investor Outlook with a 12.71% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, stands out as a significant investment opportunity. With a market capitalization..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Giant’s 19.55% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL) stands at the forefront of the biotechnology sector with a market capitalization of $10.07 billion, positioning itself as a prominent player in the healthcare industry. Focusing..

Becton, Dickinson and Company (BDX) Stock Analysis: Assessing a 7.78% Upside Potential in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $55.31..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Eyeing a 5.39% Upside Amidst Revolutionary Biotech Innovations

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) sits at an intriguing juncture for investors, presenting a combination of promising scientific advancements and complex financial metrics. As a biotech company specializing in innovative..

Incyte Corporation (INCY) Stock Analysis: Navigating the Biotech Frontier with Strong Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands as a notable player in the biotechnology sector, offering a robust portfolio of therapeutic products across various markets including the United States, Europe, Canada, and..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings and 36% Potential Upside Make It a Healthcare Gem

HealthEquity, Inc. (HQY) is a prominent player in the health information services industry, offering technology-enabled platforms that are revolutionizing the way consumers and employers manage health savings accounts and related..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Robust Growth Potential with a 12.36% Upside

Thermo Fisher Scientific Inc (TMO), a formidable player in the healthcare sector, has captured investor attention with its significant potential upside. As a leader in the diagnostics and research industry,..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 101% Potential Upside Amidst Promising Drug Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is making waves with its innovative approach to developing treatments for debilitating muscle-related diseases. With a market capitalization of..

Search

Funds

September 1, 2025

Search

Funds

September 1, 2025

FTSE 100

Funds